Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.

Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR.

Lancet Respir Med. 2018 Sep;6(9):707-714. doi: 10.1016/S2213-2600(18)30301-1. Epub 2018 Aug 9.

PMID:
30100404
2.

Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis.

Pirozzi CS, Mendoza DL, Xu Y, Zhang Y, Scholand MB, Baughman RP.

Int J Environ Res Public Health. 2018 May 26;15(6). pii: E1077. doi: 10.3390/ijerph15061077.

3.

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.

Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'Hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD.

Respir Med. 2018 Jun;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub 2018 May 5.

PMID:
29858005
4.

Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care?

Frech TM, Hess R, Biber J, Young J, Hardman A, Weeks H, Peterson KA, Scholand MB.

J Clin Rheumatol. 2018 Aug;24(5):272-274. doi: 10.1097/RHU.0000000000000715. No abstract available.

PMID:
29509559
5.

Implementation of an advance directive focus in a Chronic Multi-Organ Rare Disease Clinic.

Elorreaga N, Allred D, Ortiz G, McNeill C, Scholand MB, Frech TM.

Ann Palliat Med. 2017 Dec;6(Suppl 2):S206-S208. doi: 10.21037/apm.2017.08.06. Epub 2017 Aug 31.

6.

Oesophageal disease in systemic sclerosis: does heritability play a role?

Frech TM, Fakoya L, Gawron AJ, Wong J, Scholand MB, Sawitzke A, Peterson K.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):86-88. Epub 2017 Oct 2.

PMID:
28980899
7.

A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome.

Di Gioia SA, Connors S, Matsunami N, Cannavino J, Rose MF, Gilette NM, Artoni P, de Macena Sobreira NL, Chan WM, Webb BD, Robson CD, Cheng L, Van Ryzin C, Ramirez-Martinez A, Mohassel P, Leppert M, Scholand MB, Grunseich C, Ferreira CR, Hartman T, Hayes IM, Morgan T, Markie DM, Fagiolini M, Swift A, Chines PS, Speck-Martins CE, Collins FS, Jabs EW, Bönnemann CG, Olson EN; Moebius Syndrome Research Consortium, Carey JC, Robertson SP, Manoli I, Engle EC.

Nat Commun. 2017 Jul 6;8:16077. doi: 10.1038/ncomms16077.

8.

Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.

Sun W, Kechris K, Jacobson S, Drummond MB, Hawkins GA, Yang J, Chen TH, Quibrera PM, Anderson W, Barr RG, Basta PV, Bleecker ER, Beaty T, Casaburi R, Castaldi P, Cho MH, Comellas A, Crapo JD, Criner G, Demeo D, Christenson SA, Couper DJ, Curtis JL, Doerschuk CM, Freeman CM, Gouskova NA, Han MK, Hanania NA, Hansel NN, Hersh CP, Hoffman EA, Kaner RJ, Kanner RE, Kleerup EC, Lutz S, Martinez FJ, Meyers DA, Peters SP, Regan EA, Rennard SI, Scholand MB, Silverman EK, Woodruff PG, O'Neal WK, Bowler RP; SPIROMICS Research Group; COPDGene Investigators.

PLoS Genet. 2016 Aug 17;12(8):e1006011. doi: 10.1371/journal.pgen.1006011. eCollection 2016 Aug.

9.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

10.

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.

Raghu G, Scholand MB, de Andrade J, Lancaster L, Mageto Y, Goldin J, Brown KK, Flaherty KR, Wencel M, Wanger J, Neff T, Valone F, Stauffer J, Porter S.

Eur Respir J. 2016 May;47(5):1481-91. doi: 10.1183/13993003.01030-2015. Epub 2016 Mar 10.

11.

Effect of naturally occurring ozone air pollution episodes on pulmonary oxidative stress and inflammation.

Pirozzi C, Sturrock A, Weng HY, Greene T, Scholand MB, Kanner R, Paine R 3rd.

Int J Environ Res Public Health. 2015 May 12;12(5):5061-75. doi: 10.3390/ijerph120505061.

12.

Polymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome.

Brown SM, Grissom CK, Rondina MT, Hoidal JR, Scholand MB, Wolff RK, Morris AH, Paine R 3rd; NIH/NHLBI ARDS Network.

Exp Lung Res. 2015 Apr;41(3):155-62. doi: 10.3109/01902148.2014.983281. Epub 2014 Dec 16.

13.

Genetic discovery, rigorous statistics, and pandemic influenza.

Scholand MB, Liou TG.

Chest. 2014 Jun;145(6):1186-1188. doi: 10.1378/chest.14-0137. No abstract available.

14.

Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype.

Scholand MB, Wolff R, Crossno PF, Sundar K, Winegar M, Whipple S, Carey P, Sunchild N, Coon H.

Cough. 2014 Mar 25;10:3. doi: 10.1186/1745-9974-10-3. eCollection 2014.

15.

Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.

O'Neal WK, Anderson W, Basta PV, Carretta EE, Doerschuk CM, Barr RG, Bleecker ER, Christenson SA, Curtis JL, Han MK, Hansel NN, Kanner RE, Kleerup EC, Martinez FJ, Miller BE, Peters SP, Rennard SI, Scholand MB, Tal-Singer R, Woodruff PG, Couper DJ, Davis SM; SPIROMICS Investigators.

J Transl Med. 2014 Jan 8;12:9. doi: 10.1186/1479-5876-12-9.

16.

A semiautomated framework for integrating expert knowledge into disease marker identification.

Wang J, Webb-Robertson BJ, Matzke MM, Varnum SM, Brown JN, Riensche RM, Adkins JN, Jacobs JM, Hoidal JR, Scholand MB, Pounds JG, Blackburn MR, Rodland KD, McDermott JE.

Dis Markers. 2013;35(5):513-23. doi: 10.1155/2013/613529. Epub 2013 Oct 10.

17.

Use of a genealogical database demonstrates heritability of pulmonary fibrosis.

Scholand MB, Coon H, Wolff R, Cannon-Albright L.

Lung. 2013 Oct;191(5):475-81. doi: 10.1007/s00408-013-9484-2. Epub 2013 Jul 19.

PMID:
23867963
18.

Smoking cessation and environmental hygiene.

Pirozzi C, Scholand MB.

Med Clin North Am. 2012 Jul;96(4):849-67. doi: 10.1016/j.mcna.2012.04.014. Epub 2012 Jun 12. Review.

PMID:
22793948
19.

Low-dose naltrexone for pruritus in systemic sclerosis.

Frech T, Novak K, Revelo MP, Murtaugh M, Markewitz B, Hatton N, Scholand MB, Frech E, Markewitz D, Sawitzke AD.

Int J Rheumatol. 2011;2011:804296. doi: 10.1155/2011/804296. Epub 2011 Sep 12.

20.

Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis.

Hatton N, Frech T, Smith B, Sawitzke A, Scholand MB, Markewitz B.

Int J Clin Pract Suppl. 2011 Aug;(172):35-43. doi: 10.1111/j.1742-1241.2011.02726.x. Review.

PMID:
21736678
21.

Smoking, COPD, and 3-nitrotyrosine levels of plasma proteins.

Jin H, Webb-Robertson BJ, Peterson ES, Tan R, Bigelow DJ, Scholand MB, Hoidal JR, Pounds JG, Zangar RC.

Environ Health Perspect. 2011 Sep;119(9):1314-20. doi: 10.1289/ehp.1103745. Epub 2011 Jun 6.

22.

The vascular microenvironment and systemic sclerosis.

Frech T, Hatton N, Markewitz B, Scholand MB, Cawthon R, Patel A, Sawitzke A.

Int J Rheumatol. 2010;2010. pii: 362868. doi: 10.1155/2010/362868. Epub 2010 Aug 10.

23.

Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene.

Hersh CP, Pillai SG, Zhu G, Lomas DA, Bakke P, Gulsvik A, DeMeo DL, Klanderman BJ, Lazarus R, Litonjua AA, Sparrow D, Reilly JJ, Agusti A, Calverley PM, Donner CF, Levy RD, Make BJ, Paré PD, Rennard SI, Vestbo J, Wouters EF, Scholand MB, Coon H, Hoidal J, Silverman EK.

Am J Respir Crit Care Med. 2010 Sep 1;182(5):605-13. doi: 10.1164/rccm.200910-1586OC. Epub 2010 May 12.

24.

Airway PI3K pathway activation is an early and reversible event in lung cancer development.

Gustafson AM, Soldi R, Anderlind C, Scholand MB, Qian J, Zhang X, Cooper K, Walker D, McWilliams A, Liu G, Szabo E, Brody J, Massion PP, Lenburg ME, Lam S, Bild AH, Spira A.

Sci Transl Med. 2010 Apr 7;2(26):26ra25. doi: 10.1126/scitranslmed.3000251.

25.

Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.

Devanarayan V, Scholand MB, Hoidal J, Leppert MF, Crackower MA, O'Neill GP, Gervais FG.

COPD. 2010 Feb;7(1):51-8. doi: 10.3109/15412550903499530.

PMID:
20214463
26.

Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes.

Baker TB, Weiss RB, Bolt D, von Niederhausern A, Fiore MC, Dunn DM, Piper ME, Matsunami N, Smith SS, Coon H, McMahon WM, Scholand MB, Singh N, Hoidal JR, Kim SY, Leppert MF, Cannon DS.

Nicotine Tob Res. 2009 Jul;11(7):785-96. doi: 10.1093/ntr/ntp064. Epub 2009 May 12.

27.

High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine.

Boutin M, Berthelette C, Gervais FG, Scholand MB, Hoidal J, Leppert MF, Bateman KP, Thibault P.

Anal Chem. 2009 Mar 1;81(5):1881-7. doi: 10.1021/ac801745d.

28.

Hypercapnia effect on core cooling and shivering threshold during snow burial.

Grissom CK, McAlpine JC, Harmston CH, Radwin MI, Giesbrecht GG, Scholand MB, Morgan JS.

Aviat Space Environ Med. 2008 Aug;79(8):735-42.

PMID:
18717110
29.

A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.

Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, Singh NA, Baird L, Coon H, McMahon WM, Piper ME, Fiore MC, Scholand MB, Connett JE, Kanner RE, Gahring LC, Rogers SW, Hoidal JR, Leppert MF.

PLoS Genet. 2008 Jul 11;4(7):e1000125. doi: 10.1371/journal.pgen.1000125.

30.

The PHQ-9 as a brief assessment of lifetime major depression.

Cannon DS, Tiffany ST, Coon H, Scholand MB, McMahon WM, Leppert MF.

Psychol Assess. 2007 Jun;19(2):247-51.

PMID:
17563207
31.

Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease.

Leslie KO, Gruden JF, Parish JM, Scholand MB.

Arch Pathol Lab Med. 2007 Mar;131(3):407-23. Review.

PMID:
17516743
32.

Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension.

Elliott CG, Glissmeyer EW, Havlena GT, Carlquist J, McKinney JT, Rich S, McGoon MD, Scholand MB, Kim M, Jensen RL, Schmidt JW, Ward K.

Circulation. 2006 May 30;113(21):2509-15. Epub 2006 May 22.

PMID:
16717148
33.

Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking.

Cannon DS, Baker TB, Piper ME, Scholand MB, Lawrence DL, Drayna DT, McMahon WM, Villegas GM, Caton TC, Coon H, Leppert MF.

Nicotine Tob Res. 2005 Dec;7(6):853-8.

PMID:
16298720
34.

Hypercapnia increases core temperature cooling rate during snow burial.

Grissom CK, Radwin MI, Scholand MB, Harmston CH, Muetterties MC, Bywater TJ.

J Appl Physiol (1985). 2004 Apr;96(4):1365-70. Epub 2003 Dec 5.

35.

Clinical approach to interstitial lung disease.

Scholand MB.

Semin Ultrasound CT MR. 2002 Aug;23(4):269-74. Review.

PMID:
12465684
36.

Normal oxygenation and ventilation during snow burial by the exclusion of exhaled carbon dioxide.

Radwin MI, Grissom CK, Scholand MB, Harmston CH.

Wilderness Environ Med. 2001 Winter;12(4):256-62.

PMID:
11769922

Supplemental Content

Loading ...
Support Center